Safe semaglutide use requires regular monitoring: dose escalation every 4 weeks, biweekly or monthly check-ins during titration, and assessment for pancreatitis symptoms, gallbladder complications, and thyroid nodule changes
A randomized clinical trial shows that only 13% of people discontinued semaglutide compared to 27.6% for liraglutide in a 68-week trial
That might sound like a lot, but it breaks down to just over 20 minutes a day
Managing your health often comes with its own set of challenges, and for those using semaglutide injections, gastrointestinal side effects like diarrhea can be an unexpected hurdle
Metformin, SGLT2 inhibitors, and thiazolidinediones generally do not require dose modification when combined with semaglutide, as hypoglycemia risk remains low with these agents
Yin, J., Xing, H., & Ye, J